Clinical trial
Fludeoxyglucose F 18 Positron Emission Tomography and Magnetic Resonance…
NCT00060008 · Children's Hospital of Philadelphia, Other · Terminated
Key facts
| NCT number | NCT00060008 |
|---|---|
| Title | Fludeoxyglucose F 18 Positron Emission Tomography and Magnetic Resonance Perfusion Imaging in Patients With Neurofibromatosis 1 and Plexiform Neurofibroma |
| Official title | Novel Imaging Modalities For Plexiform Neurofibromas |
| Lead sponsor | Children's Hospital of Philadelphia, Other |
| Status | Terminated |
| Study type | Interventional |
| Conditions | Neurofibromatosis Type 1, Precancerous Condition |
| Intervention type | Radiation |
| Interventions | fludeoxyglucose F 18, gadopentetate dimeglumine |
| Enrollment | 18 |
| Start date | Apr 1, 2002 |
| Primary completion | May 1, 2011 |
| Completion | May 1, 2011 |
| First posted | May 7, 2003 |
| Last update posted | Apr 4, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: